Is Cardio Diagnostics Holdings, Inc. (CDIO) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 6.9% / 30% | 80.9% / 30% | 0.2% / 30% | 3.05% / 5% | ✗ NOT HALAL |
| DJIM | 6.9% / 33% | 80.9% / 33% | 0.2% / 33% | 3.05% / 5% | ✗ NOT HALAL |
| MSCI | 6.2% / 33% | 73.7% / 33% | 0.2% / 33% | 3.05% / 5% | ✗ NOT HALAL |
| S&P | 6.9% / 33% | 80.9% / 33% | 0.2% / 33% | 3.05% / 5% | ✗ NOT HALAL |
| FTSE | 6.2% / 33% | 73.7% / 33% | 0.2% / 50% | 3.05% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 100.0% | |
| Operating Margin | -41159.6% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -78.6% | |
| Return on Assets (ROA) | -44.1% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$5M |
| Free Cash Flow | -$5M |
| Total Debt | $663,099 |
| Debt-to-Equity | 10.0 |
| Current Ratio | 9.8 |
| Total Assets | $11M |
Price & Trading
| Last Close | $1.88 |
| 50-Day MA | $2.69 |
| 200-Day MA | $3.45 |
| Avg Volume | 4.2M |
| Beta | 2.2 |
|
52-Week Range
$0.97
| |
About Cardio Diagnostics Holdings, Inc. (CDIO)
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Cardio Diagnostics Holdings, Inc. (CDIO) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Cardio Diagnostics Holdings, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Cardio Diagnostics Holdings, Inc.'s debt ratio?
Cardio Diagnostics Holdings, Inc.'s debt ratio is 6.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 6.2%.
What are Cardio Diagnostics Holdings, Inc.'s key financial metrics?
Cardio Diagnostics Holdings, Inc. has a market capitalization of $6M, and revenue of $34,890. Return on equity stands at -78.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.